The goal of the Hematology and Oncology Fellowship is to train leaders in oncology. We recognize that these leaders may achieve in a diverse range of domains, including cancer prevention, health policy, clinical care, patient-based translational research and basic science.
With world class laboratory and clinical research faculty, renowned expert clinicians and a patient base that is unmatched anywhere else in the world, we are uniquely positioned to train a new generation of experts in each of these areas.
Our fellows are given the structure and supervision required to ensure that each is a well-trained, competent oncologist, and are given the protected time required to build the beginnings of an academic career. During this protected time, fellows can choose to work in a basic science laboratory, develop skills in clinical and translational research, pursue a master’s degree, train in quality improvement methods, develop teaching skills required to be a physician educator, or a variety of other pursuits.
Two of the most unique components of our program are weekly protected dedicated time to learning during Academic Tuesday, and instruction and support for grant writing, particularly pursuing awards such as the Young Investigator Award.
Ultimately, our success is judged by the ability of each fellow to excel in their own defined professional goals.
Meet Our Fellows
We offer a fully integrated, three-year hematology and medical oncology program. The first 18 months of training incorporates 12 months of clinical rotation, which includes both solid tumors and hematologic malignancies with 6 months of benign hematology. The ACGME core competencies and milestones are achieved through a required set of rotations, a didactic curriculum and elective rotations designed to broaden the base of knowledge.
Our fellows, faculty, and program are continuously evaluated to ensure success in achieving these competencies, goals and objectives. For the remaining 18 months, the fellow is encouraged to pursue clinical research pursuits and to develop skills and projects to compete for national presentations and awards. Our program offers flexibility during this time period in which fellows can pursue a wide range of interests. Some of the opportunities include spending time in a basic science laboratory, developing skills in clinical and translational research, pursuing a master’s degree, training in quality improvement methods, developing teaching skills required to be a clinician educator, to name a few.
The general structure of the rotations is listed below, with each rotation lasting approximately one month. While most fellows double-board in hematology and medical oncology, some single board in medical oncology.
Medical Oncology Rotations:
- Breast Medical Oncology
- GI Medical Oncology
- GU Medical Oncology
- Melanoma Medical Oncology
- Neuro Oncology/Gynecological Oncology
- Palliative Care
- Sarcoma Medical Oncology
- Thoracic Head and Neck Medical Oncology
- LBJ General Hospital Oncology Consultation Services
Maligant Hematology Rotations:
- Stem Cell Transplant
Benign Hematology Rotations:
- MD Anderson Hematology Consults
- LBJ General Hospital Hematology Consults
- Memorial Hermann Hematology Consults
- Houston Methodist Hematology Consults
- Ben Taub Hematology Consults
- Benign Hematology Outpatient Clinics
Fellows have formal education through clinical teaching, lectures, and conferences. Some educational highlights of the hematology and oncology fellowship program include:
Academic Tuesday: This is a half-day dedicated to fellow education. This time is protected from other clinical duties. Fellows attend the Division of Cancer Medicine Grand Rounds, then have 2-3 lectures taught by faulty on a rotating list of topics in hematology and oncology, covering a core curriculum while also highlighting the most recent work in each field. Fellows also give one lecture per year, either on an interesting case, a journal club, or a research presentation.
LBJ Clinic: While participating in the LBJ General Hospital Oncology clinic, fellows participate in a morning report designed to discuss all new patients and provide learning points. Faculty also lead a curriculum designed to build the fellows’ fund of knowledge. Fellows learn from faculty in the clinical setting as well. Finally, fellows participate in multidisciplinary tumor boards with several specialties with the goal of coming to a consensus for a patient’s care. Fellows are expected to be the one primarily responsible for a patient’s care at LBJ, offering a great deal of autonomy and a unique and valuable learning experience.
MD Anderson Board Review Course: MD Anderson hosts a week-long board review course each fall. Fellows are given course materials and are welcome to attend lectures, taught by leading faculty across the country.
Intro to Research Series: First-year fellows participate in an Introduction to Research Series, in which leaders at MD Anderson highlight research opportunities that fellows can pursue throughout their time in the program. Fellows hear from each department within the Division of Cancer Medicine about topics that include:
- Support for Grant Writing
- Basic Science
- Clinical Investigation
- Translational Research
- Quality Improvement
- Value Based Health Care
Educational tracks have been developed for clarifying the expected clinical and research expectations of each fellow. All fellows must declare a training track at the beginning of their second year. There are common elements which apply to all tracks:
Following fellowship training, fellows may compete for entry into the Division of Cancer Medicine Advanced Scholar Program. This program provides for 100% protected time to concentrate their efforts intensively in an area of investigation and practice started in the fellowship program. Completion of the Advanced Scholar Program positions each scholar for success in a tenure-track position in academic medicine.
ERAS opens for new applications on July 1, 2018. Deadline for submission of applications for the 2019 Academic Year will be Aug. 31, 2018. Interviews will tentatively be conducted during the months of September and October 2018.
Applications are accepted through the Electronic Residency Application System (ERAS) only.
Required documents for all applicants:
- Curricula vitae
- Personal statement
- USMLE or COMLEX transcript
- (2) Letters of recommendation, plus
- (1) Letter of recommendation from your program director
- Medical school transcript
- Photograph (optional)
Meet Our Fellows
Daniel Johnson, M.D.
Hometown: Metairie, Louisiana
Residency : Louisiana State University Health Sciences Center
Haven Garber, M.D.
Hometown: Greensboro, North Carolina and Pickerington, Ohio
Residency : Beth Israel Deaconess Medical Center
Jonathan Mizrahi, M.D.
Hometown: Jacksonville, Florida
Residency : Washington University in St. Louis
Alexander Andreev-Drakhlin, M.D.
Hometown: Saint Petersburg, Russia
Residency: University of Pittsburgh
Joseph Moore, M.D.
Hometown: Wichita, Kansas
Residency: University of Texas Southwestern Medical Center
Demetria Smith-Graziani, M.D.
Hometown: Stone Mountain, Goergia
Residency: Emory University School of Medicine
Stephanie Williams, M.D.
Hometown: Akron, Ohio
Residency: Mayo Clinic
Meredith Sellers Pelster, M.D.
Hometown: Cleveland, Tennessee
Residency: Northwestern Memorial Hospital
Bilal A. Siddiqui, M.D.
Hometown: London, Ontario, Canada
Residency: Beth Israel Deaconess Medical Center
Class of 2018
Roman Groisberg, M.D. - Rutgers Cancer Institute of New Jersey
Prateek Gulhati, M.D., Ph.D. - MD Anderson Cancer Center (Advanced Scholar)
Boyu Hu, M.D. - Huntsman Cancer Institute, University of Utah
Paul Koller, M.D. - MD Anderson Cancer Center (Advanced Scholar)
James Link, Ph.D., M.D. - Dignity Health/Marian Regional Medical Center
Hossein Maymani, M.D. - Rocky Mountain Cancer Center, Longmont, CO
Meredith McKean, M.D., MPH - Sarah Cannon Research Institute, Nashville, TN
Pavlos Msaouel, M.D., Ph.D. - MD Anderson Cancer Center, Houston, TX
Maliha Nusrat, M.D. - MD Anderson Cancer Center, Houston, TX
Amanda Parkes, M.D. - University of Wisconsin School of Medicine and Public Health, Madison, WI
Christine Parseghian, M.D. - MD Anderson Cancer Center, Houston, TX
Patrick Pilie, M.D. - MD Anderson Cancer Center (Advanced Scholar)
Shiraj Sen, M.D., Ph.D. - Sarah Cannon Research Institute, Denver, CO
Catherine Butler-Gunn, J.D.
Division of Cancer Medicine GME Programs
Division of Cancer Medicine
UT MD Anderson Cancer Center
1400 Holcombe Blvd., Unit 463
Houston, TX 77030
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. If you are applying for a GME fellowship or residency program starting on or after July 1, 2016, please be advised that MD Anderson will have instituted a tobacco-free hiring process as part of its efforts to achieve these goals. If you are offered an appointment, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws. If you do not pass the urine drug screening which includes testing for tobacco compounds, you CANNOT be appointed at MD Anderson. Should you fail to meet this contingency, MD Anderson will withdraw your offer of appointment for the academic year. You may reapply for the following academic year, but there are no guarantees that you will be offered a position as many of our programs are already filled for several years out.